source
- WuXi AppTec posts six-month revenue higher than Lonza for first timeWuXi AppTec, a Chinese contract manufacturing organization, has reported that its revenue over the most recent six-month period exceeded that of Swiss CDMO Lonza for the first time. The increase c…
- Sanofi pauses phase 2 bronchiectasis trial of SAR445399 for strategic reasonsSanofi has halted a phase 2 study of its monoclonal antibody SAR445399 in adults with non‑cystic fibrosis bronchiectasis. The trial, which began in April, was a randomized, double‑blind, placebo‑co…